Thanks Parto I think you recall correctly at +5. I had conservatively assumed +2 per 6 month data point but certainly not that this could have been factored into the data. You would think they would need to state this on the graph if it was - not that labelling is their strong point.
Performance seems highly understated but I appreciate they have to follow a protocol on claims .
Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-64
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.18M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2463308 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 274836 | 3 |
View Market Depth
| Last trade - 16.12pm 10/07/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |
Day chart unavailable